2022 Global Predictions Whitepaper

whitePaper | February 11, 2022

We are living through the greatest challenge our health and care system has ever faced. The Coronavirus (Covid-19) pandemic caused an unprecedented external shock,

whitePaper | January 27, 2023

Big Pharma conducted most of its early-stage clinical studies in the West before incorporating Asian locations in later phase studies. Though the Asian region had limited experience in the beginning, over time, researchers’ and local regional experience.

whitePaper | August 3, 2022

Stages 1 and 2 of the Meaningful Use guidelines incented healthcare organizations to adopt EHR technology, but they did not offer best practices for how the accumulated patient data should be handled.

whitePaper | April 28, 2022

The authors would like to express their gratitude to those who contributed to this research either by participating in the surveys carried out during the EIT Health Morning Health Talks or the in-depth interviews.

whitePaper | December 27, 2022

Year after year, the Life Sciences industry expands at a breakneck pace, with pharmaceutical development leading the way. Regulatory agencies prioritize patient safety in this highly regulated industry.

whitePaper | January 19, 2023

Successful execution of clinical trials requires the orchestration of multiple moving parts, with everything from protocol design and patient visit schedules.